Monday, Nov 27, 2023 · SEC filings
What the smart money revealed on Nov 27
360 insider filings came in. We hid 54 planned (10b5-1) sellers and 157 people whose filings were routine, like grants and tax withholding.
Dentsply Sirona (XRAY) Director Gregory Lucier bought $314K
10,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 8 checked quarters beat the typical stock 6 months later.
Perrigo (PRGO) EVP and Chro Robert Willis bought $172K
5,550 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.
Topgolf Callaway Brands (CALY) President and CEO Oliver Brewer III bought $128K
11,000 shares on the open market. Not a grant or an option exercise.
Pimco Corporate & Income Opportunity Fund (PTY) Director Grace Vandecruze bought $102K
7,513 shares on the open market. Not a grant or an option exercise.
Honeywell International (HON) Director Darius Adamczyk sold $7.86M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 180,453 shares directly.
Medpace (MEDP) CEO August Troendle sold $6.95M
Not marked as a planned 10b5-1 sale. Sold 1% of the shares they held directly. Still holds 5.69M shares.
Avnet (AVT) Director James Lawrence sold $387K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 46 more real buys
Show 78 more real sales
13F season
Holdings as of Sep 30, 2023 were due Nov 14
40 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Nov 21–27
Open-market buys by officers and directors, filed in the 7 days up to Nov 27.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.